tiprankstipranks
Trending News
More News >
American Well (AMWL)
NYSE:AMWL
US Market

American Well (AMWL) Risk Analysis

Compare
1,145 Followers
Public companies are required to disclose risks that can affect the business and impact the stock. These disclosures are known as “Risk Factors”. Companies disclose these risks in their yearly (Form 10-K), quarterly earnings (Form 10-Q), or “foreign private issuer” reports (Form 20-F). Risk factors show the challenges a company faces. Investors can consider the worst-case scenarios before making an investment. TipRanks’ Risk Analysis categorizes risks based on proprietary classification algorithms and machine learning.

American Well disclosed 10 risk factors in its most recent earnings report. American Well reported the most risks in the “Legal & Regulatory” category.

Risk Overview Q3, 2024

Risk Distribution
10Risks
50% Legal & Regulatory
20% Finance & Corporate
20% Tech & Innovation
10% Production
0% Ability to Sell
0% Macro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
This chart displays the stock's most recent risk distribution according to category. TipRanks has identified 6 major categories: Finance & corporate, legal & regulatory, macro & political, production, tech & innovation, and ability to sell.

Risk Change Over Time

S&P500 Average
Sector Average
Risks removed
Risks added
Risks changed
American Well Risk Factors
New Risk (0)
Risk Changed (0)
Risk Removed (0)
No changes from previous report
The chart shows the number of risks a company has disclosed. You can compare this to the sector average or S&P 500 average.

The quarters shown in the chart are according to the calendar year (January to December). Businesses set their own financial calendar, known as a fiscal year. For example, Walmart ends their financial year at the end of January to accommodate the holiday season.

Risk Highlights Q3, 2024

Main Risk Category
Legal & Regulatory
With 5 Risks
Legal & Regulatory
With 5 Risks
Number of Disclosed Risks
10
No changes from last report
S&P 500 Average: 31
10
No changes from last report
S&P 500 Average: 31
Recent Changes
0Risks added
0Risks removed
0Risks changed
Since Sep 2024
0Risks added
0Risks removed
0Risks changed
Since Sep 2024
Number of Risk Changed
0
No changes from last report
S&P 500 Average: 3
0
No changes from last report
S&P 500 Average: 3
See the risk highlights of American Well in the last period.

Risk Word Cloud

The most common phrases about risk factors from the most recent report. Larger texts indicate more widely used phrases.

Risk Factors Full Breakdown - Total Risks 10

Legal & Regulatory
Total Risks: 5/10 (50%)Above Sector Average
Regulation3 | 30.0%
Regulation - Risk 1
We have incurred significant losses in each period since our inception. We incurred net losses of $679.2 million, $272.1 million and $176.8 million for the years ended December 31, 2023, 2022 and 2021, respectively. As of December 31, 2023, we had an accumulated deficit of $1,757.8 million. These losses and accumulated deficit reflect the substantial investments we made to acquire new clients and develop our enterprise platform and software as a service. We intend to continue scaling our business to increase our client, patient, member and provider bases, broaden the scope of services we offer, invest in research and development and expand the applications of our technology through which consumers can access our services. These efforts may prove more expensive than we currently anticipate, and we may not succeed in increasing our revenue sufficiently to offset these higher expenses. We cannot assure you that we will achieve profitability in the future or that, if we do become profitable, we will be able to sustain or increase profitability. Our prior losses, combined with our expected future losses, have had and will continue to have an adverse effect on our stockholders’ equity and working capital. A significant portion of our revenue comes from a limited number of clients and we may be unable to retain our key clients. We rely on a limited number of clients for a substantial portion of our total revenue. For the years ended December 31, 2023, 2022 and 2021, our largest client, Elevance, accounted for 24%, 23% and 25% of our revenue, respectively. For the years ended December 31, 2023, 2022 and 2021, our top ten clients by revenue accounted for 51%, 47% and 44% of our total revenue, respectively. The loss of any of our key clients, or a failure of some of them to renew or expand their subscriptions, could have a significant impact on our revenue. Our clients may choose to cancel, not renew or otherwise limit their use of our offerings for a variety of reasons described in this “Risk Factors” section, including mergers and acquisitions involving our clients. Further, as we rely on our reputation and recommendations from key clients in order to promote our solution to potential new clients, the loss of any of our key clients could adversely affect our reputation and our ability to obtain new clients. We may need additional capital to support the growth of our business, which may not be available to us on acceptable terms or at all. Our operations have consumed substantial amounts of cash since inception, and we intend to continue scaling our business to increase our client, patient, member and provider bases, broaden the scope of services we offer, invest in research and development and expand the applications of our technology through which consumers can access our services. For the years ended December 31, 2023, 2022 and 2021, our net cash used in operating activities was $148.3 million, $192.3 million and $141.5 million respectively. As of December 31, 2023, we had $372.0 million of cash, cash equivalents and short-term investments, which are held for working capital purposes. Our future capital requirements may be significantly different from our current estimates and will depend on many factors, including our growth rate, subscription renewal activity, the timing and extent of spending to support development efforts, the expansion of sales and marketing activities, the introduction of new or enhanced services and the continuing market acceptance of digital care. Accordingly, we may need to engage in equity or debt financings or collaborative arrangements to secure additional funds. If we raise additional funds through further issuances of equity or convertible debt securities, our existing stockholders could suffer significant dilution, and any new equity securities we issue could have rights, preferences and privileges superior to those of holders of our Class A common stock. Any debt financing secured by us in the future could require us to dedicate a substantial amount of cash for interest payments and involve restrictive covenants relating to our capital-raising activities and other financial and operational matters, which may make it more difficult for us to obtain additional capital, operate our business and pursue business opportunities, including potential acquisitions. We have incurred and may in the future incur non-cash impairment charges. In the year ended December 31, 2023, we incurred goodwill impairment charges of $436.5 million and, if in the future there is a sustained decline in our stock price, adverse changes in our projected cash flows, and/or changes in key assumptions, including but not limited to lower revenue growth, lower operating margin, and/or a lower terminal growth rate, we may be required to conduct additional impairment testing of our other intangibles and/or long-lived assets and subsequently record additional non-cash impairment charge. Such a non-cash charge would likely have a material adverse effect on our consolidated statements of operations and balance sheets in the reporting period of the charge. For additional information, see Part II, Item 7: Management’s Discussion & Analysis of Financial Condition and Results of Operations under the sub-heading “Critical Accounting Policies and Estimates—Goodwill and Intangible Assets.”
Regulation - Risk 2
Risks Related to Government Regulation
We must comply with a wide range of government regulations, including anti-corruption, trade compliance, export control, healthcare reimbursement and fraud and abuse laws. These include the Foreign Corrupt Practices Act (FCPA), the U.K. Bribery Act, the federal Anti-Kickback Statute, HIPAA, and various state laws and international data protection regulations. Compliance with these laws and regulations may restrict our operations, impose additional costs and require changes to our business practices. A failure to comply, or even the perception of noncompliance, could result in significant penalties, adverse publicity, and harm to our business and reputation. In addition, changes in legislation or regulatory interpretation could force us to modify our practices at significant cost, and enforcement actions or litigation arising from alleged violations could distract management and adversely affect our business.
Regulation - Risk 3
Because we do not anticipate paying any cash dividends on our capital stock, capital appreciation will be your sole source of gain, if any. We have never declared or paid cash dividends on our capital stock. We currently intend to retain all of our future earnings, if any, to finance the growth and development of our business. Any future debt agreements may preclude us from paying dividends. As a result, capital appreciation, if any, of our Class A common stock will be your sole source of gain for the foreseeable future.
Litigation & Legal Liabilities1 | 10.0%
Litigation & Legal Liabilities - Risk 1
Risks Related to Litigation and Liability
We may become subject to medical liability claims, which could cause us to incur significant expenses and require us to pay substantial damages if not fully covered by insurance. Our business involves providing digital care, and both we and our affiliated medical group (AMG) carry insurance covering medical malpractice claims in amounts we believe to be appropriate. However, if successful claims exceed our coverage limits, significant damage awards could result. Additionally, any claims made against us that are not completely covered by insurance could be very costly to defend. Such claims may divert management’s attention, reduce client confidence and adversely affect our reputation, business, and financial results. Moreover, our efforts to limit our liability through contractual limitations may not fully protect us from claims arising in connection with our services.
Taxation & Government Incentives1 | 10.0%
Taxation & Government Incentives - Risk 1
Risks Related to Taxation
In August 2022, the Inflation Reduction Act (the “IRA”) was signed into law, which includes the implementation of a new corporate alternative minimum tax (CAMT). The CAMT imposes a minimum tax on the adjusted financial statement income (AFSI) for applicable corporations with average annual AFSI over a three-year period in excess of $1 billion. Although we do not currently believe that we will be subject to the CAMT in the near future, uncertainties remain regarding its interpretation and application. Future growth in our business or changes in guidance could result in the CAMT having a material effect on our corporate tax liability and our consolidated effective tax rate. In addition, our ability to use our net operating losses and credit carryforwards to offset taxable income may be subject to limitations under Internal Revenue Code Sections 382 and 383, and changes in our stock ownership could trigger such limitations.
Finance & Corporate
Total Risks: 2/10 (20%)Below Sector Average
Share Price & Shareholder Rights1 | 10.0%
Share Price & Shareholder Rights - Risk 1
Risks Related to Ownership of Our Class A Common Stock
For so long as any shares of our Class B common stock remain outstanding, our Founders will at all times hold at least 51% of the voting power of the Company. As a result, our Founders together will control all matters submitted to our stockholders for approval, including director elections, mergers, asset sales and other significant transactions. Even if a Founder's Class B shares are converted into Class A shares, their combined voting power would still exceed 51% so long as Class B shares remain outstanding, thereby diluting the relative influence of Class A common stockholders. This concentrated control may limit your ability to influence corporate matters and could adversely affect the market price and liquidity of our Class A common stock. Additionally, our Founders' control may enable them to make strategic decisions, pursue acquisitions or adopt corporate governance practices that may not be in the best interest of other stockholders. Provisions in our certificate of incorporation and by-laws—including those authorizing multiple classes of common stock, staggered board elections, and various restrictions on stockholder actions—may further entrench our management and limit opportunities for a change of control.
Corporate Activity and Growth1 | 10.0%
Corporate Activity and Growth - Risk 1
Risks Related to Strategic Initiatives
We may acquire or invest in other companies, software products, services or technologies that we believe could complement or expand our solution. However, such acquisitions or investments could divert our management’s attention, result in dilution to our stockholders, and disrupt our operations. We may face difficulties identifying attractive opportunities, completing transactions on acceptable terms, and integrating any acquisitions successfully. Even if we complete an acquisition, there is no assurance that the acquired business will provide the anticipated benefits. Potential challenges include the inability to integrate new technologies, unanticipated costs or liabilities, difficulties aligning disparate operations and accounting systems, diversion of management attention and adverse effects on our existing client relationships.
Tech & Innovation
Total Risks: 2/10 (20%)Below Sector Average
Trade Secrets1 | 10.0%
Trade Secrets - Risk 1
Risks Related to Intellectual Property
Our success depends in part on our ability to maintain, protect and enforce our intellectual property and proprietary rights. We rely upon a combination of patent, trademark and trade secret laws, as well as license and access agreements and other contractual provisions, to protect our patent portfolio and other intellectual property. However, these laws, procedures and agreements provide only limited protection, and our intellectual property rights may be challenged, invalidated, circumvented, infringed, diluted or misappropriated. We attempt to protect our intellectual property and proprietary information by requiring our employees, consultants and certain contractors to execute confidentiality and assignment of inventions agreements. Despite these measures, we may not obtain these agreements in all circumstances or the individuals may not fully comply with their terms. Should any of our intellectual property rights be compromised, our competitive position could be harmed.
Technology1 | 10.0%
Technology - Risk 1
Risks Related to Information Technology
We rely on data center providers, Internet infrastructure, bandwidth providers, third-party computer hardware and software, other third parties and our own systems for providing services to our clients and consumers, and any failure or interruption in the services provided by these third parties or our own systems could expose us to litigation and negatively impact our relationships with clients, adversely affecting our brand and our business. We serve all of our U.S. based clients and consumers from two geographically dispersed data centers. While we control and have access to our servers, we do not control the operation of these facilities. The owners of our data center facilities have no obligation to renew their agreements with us on commercially reasonable terms, or at all. If we are unable to renew these agreements on commercially reasonable terms, or if one of our data center operators is acquired, we may be required to transfer our servers and other infrastructure to new facilities, which could incur significant costs and possible service interruptions. Problems faced by our third-party data center locations with telecommunications network providers, or with the systems by which our providers allocate capacity to clients, could adversely affect the experience of our clients and consumers. Additionally, if our data centers fail to keep up with our growing capacity needs, rapid business expansion could affect service levels or cause system failures. Any changes in third-party service levels at our data centers or any disruptions with our solution could adversely affect our reputation, damage clients’ and consumers’ data, result in lengthy service interruptions, reduce our revenue, force us to offer refunds or subject us to potential liability, and adversely affect client renewal rates. Furthermore, our ability to deliver our Internet-based services depends on the development and maintenance of the Internet infrastructure by third parties. Should catastrophic events or other disruptions occur, we could experience extended system unavailability, which would negatively impact our business.
Production
Total Risks: 1/10 (10%)Below Sector Average
Costs1 | 10.0%
Costs - Risk 1
Risks Related to Our Business and Industry
The digital care market is still developing and volatile and may develop slower than we expect and be subject to negative publicity. The digital care market is relatively new and unproven, and it is uncertain whether it will achieve and sustain high levels of demand, consumer acceptance and market adoption. Our success will depend to a substantial extent on the willingness of our clients’ members or patients to use, and to increase the frequency and extent of their utilization of, our services, as well as on our ability to demonstrate the value of digital care to employers, health plans, government agencies and other purchasers of healthcare for beneficiaries. Negative publicity concerning our services or the digital care market as a whole could limit market acceptance of our services. For example, there has been and continue to be substantial media coverage in the U.S. surrounding mental health and virtual health services, including the virtual prescription of mental health prescription drugs. Similarly, individual and healthcare industry concerns or negative publicity regarding patient confidentiality and privacy in the context of digital care could limit market acceptance of our healthcare services. If our clients, or their members or patients, do not perceive the benefits of our services, or if our services are not competitive, then our market may not develop at all, or it may develop more slowly than we expect. If any of these events occurs, it could have a material adverse effect on our business, financial condition or results of operations. Rapid technological change in our industry presents us with significant risks and challenges. The digital care market is characterized by rapid technological change, changing consumer requirements, short product lifecycles and evolving industry standards. Our success will depend on our ability to enhance our solution with next-generation technologies and to develop or to acquire and market new services to access new consumer populations. There is no guarantee that we will possess the resources, either financial or personnel, for the research, design and development of new applications or services, or that we will be able to utilize these resources successfully and avoid technological or market obsolescence. Further, there can be no assurance that technological advances by one or more of our competitors or future competitors will not result in our present or future software-based products and services becoming uncompetitive or obsolete. We operate in a competitive industry and may not be able to compete effectively. While the digital care market is in an early stage of development, it is competitive and we expect it to attract increased competition, which could make it difficult for us to succeed. We currently face competition in the digital care delivery market from a range of companies, including specialized software and solution providers that offer similar solutions, often at substantially lower prices, and that are continuing to develop additional products and becoming more sophisticated and effective. Our competitors in the digital care delivery market range from traditional digital care players such as Teladoc, Included Health and MDLive; video communications players such as Zoom or Microsoft Teams; physician networks or tools such as Doximity and Caregility; technology companies such as Amazon; and EHR players (which are also partners) such as Epic, Cerner, Allscripts and athenahealth. Competition could result in continued pricing pressures, which is likely to lead to price declines in certain product segments, which could negatively impact our sales, profitability and market share. Some of our competitors may have greater name recognition, longer operating histories and significantly greater resources than we do. Further, our current or potential competitors may be acquired by third parties with greater available resources. As a result, our competitors may be able to respond more quickly and effectively than we can to new or changing opportunities, technologies, standards or client requirements and may have the ability to initiate or withstand substantial price competition. In addition, current and potential competitors have established, and may in the future establish, cooperative relationships with vendors of complementary products, technologies or services to increase the availability of their solutions in the marketplace. Accordingly, new competitors or alliances may emerge that have greater market share, a larger client base, more widely adopted proprietary technologies, greater marketing expertise, greater financial resources and larger sales forces than we have, which could put us at a competitive disadvantage. Our competitors could also be better positioned to serve certain segments of the digital care market, which could create additional price pressure. In addition, many healthcare provider organizations are consolidating to create integrated healthcare delivery systems with greater market power. As provider networks and managed care organizations consolidate, thus decreasing the number of market participants, competition to provide products and services like ours could become more intense, and the importance of establishing and maintaining relationships with key industry participants could increase. These industry participants may try to use their market power to negotiate price reductions for our products and services. In light of these factors, even if our solution is more effective than those of our competitors, current or potential clients may accept competitive solutions in lieu of purchasing our solution. If healthcare reform legislation and other changes in the healthcare industry and in healthcare spending occur, our revenue may be adversely affected. Our revenue is dependent on the healthcare industry and could be affected by changes in healthcare spending, reimbursement and policy. Initiatives at the United States federal and state levels may further reduce payments and alter reimbursement dynamics. We expect that additional state and federal healthcare reform measures will be adopted in the future, any of which could limit the amounts paid for healthcare products and services, which could adversely affect our business, financial condition and results of operations. If growth in the number of individuals covered by our health systems and health plans decreases, or if the number of products or services that we are able to sell to our clients decreases due to legal, economic or business developments, our revenue will likely decrease. In addition, if our existing clients fail to renew their contracts or renew on less favorable terms, our revenue may decline or future revenue growth may be constrained. Additional factors that could affect our ability to sell products and services include failure of our clients to be successful in offering our products, changes in the nature or operations of our clients, price, performance and functionality of our solution, our development and introduction of additional or improved solutions and our clients’ acceptance of such solutions, availability, price, performance and functionality of competing solutions, our ability to develop and sell complementary products and services, stability of our hosting infrastructure, changes in healthcare laws, regulations or trends, and the business environment of our clients, including headcount reductions. In addition, our marketing efforts depend significantly on our ability to call upon our current clients to provide positive references to new, potential clients. Given our limited number of long-term clients, the loss or dissatisfaction of any client could substantially harm our brand and reputation, inhibit widespread adoption of our solution and impair our ability to attract new clients. Any such consequences could lower client retention rates and have a material adverse effect on our business, financial condition and results of operations.
See a full breakdown of risk according to category and subcategory. The list starts with the category with the most risk. Click on subcategories to read relevant extracts from the most recent report.

FAQ

What are “Risk Factors”?
Risk factors are any situations or occurrences that could make investing in a company risky.
    The Securities and Exchange Commission (SEC) requires that publicly traded companies disclose their most significant risk factors. This is so that potential investors can consider any risks before they make an investment.
      They also offer companies protection, as a company can use risk factors as liability protection. This could happen if a company underperforms and investors take legal action as a result.
        It is worth noting that smaller companies, that is those with a public float of under $75 million on the last business day, do not have to include risk factors in their 10-K and 10-Q forms, although some may choose to do so.
          How do companies disclose their risk factors?
          Publicly traded companies initially disclose their risk factors to the SEC through their S-1 filings as part of the IPO process.
            Additionally, companies must provide a complete list of risk factors in their Annual Reports (Form 10-K) or (Form 20-F) for “foreign private issuers”.
              Quarterly Reports also include a section on risk factors (Form 10-Q) where companies are only required to update any changes since the previous report.
                According to the SEC, risk factors should be reported concisely, logically and in “plain English” so investors can understand them.
                  How can I use TipRanks risk factors in my stock research?
                  Use the Risk Factors tab to get data about the risk factors of any company in which you are considering investing.
                    You can easily see the most significant risks a company is facing. Additionally, you can find out which risk factors a company has added, removed or adjusted since its previous disclosure. You can also see how a company’s risk factors compare to others in its sector.
                      Without reading company reports or participating in conference calls, you would most likely not have access to this sort of information, which is usually not included in press releases or other public announcements.
                        A simplified analysis of risk factors is unique to TipRanks.
                          What are all the risk factor categories?
                          TipRanks has identified 6 major categories of risk factors and a number of subcategories for each. You can see how these categories are broken down in the list below.
                          1. Financial & Corporate
                          • Accounting & Financial Operations - risks related to accounting loss, value of intangible assets, financial statements, value of intangible assets, financial reporting, estimates, guidance, company profitability, dividends, fluctuating results.
                          • Share Price & Shareholder Rights – risks related to things that impact share prices and the rights of shareholders, including analyst ratings, major shareholder activity, trade volatility, liquidity of shares, anti-takeover provisions, international listing, dual listing.
                          • Debt & Financing – risks related to debt, funding, financing and interest rates, financial investments.
                          • Corporate Activity and Growth – risks related to restructuring, M&As, joint ventures, execution of corporate strategy, strategic alliances.
                          2. Legal & Regulatory
                          • Litigation and Legal Liabilities – risks related to litigation/ lawsuits against the company.
                          • Regulation – risks related to compliance, GDPR, and new legislation.
                          • Environmental / Social – risks related to environmental regulation and to data privacy.
                          • Taxation & Government Incentives – risks related to taxation and changes in government incentives.
                          3. Production
                          • Costs – risks related to costs of production including commodity prices, future contracts, inventory.
                          • Supply Chain – risks related to the company’s suppliers.
                          • Manufacturing – risks related to the company’s manufacturing process including product quality and product recalls.
                          • Human Capital – risks related to recruitment, training and retention of key employees, employee relationships & unions labor disputes, pension, and post retirement benefits, medical, health and welfare benefits, employee misconduct, employee litigation.
                          4. Technology & Innovation
                          • Innovation / R&D – risks related to innovation and new product development.
                          • Technology – risks related to the company’s reliance on technology.
                          • Cyber Security – risks related to securing the company’s digital assets and from cyber attacks.
                          • Trade Secrets & Patents – risks related to the company’s ability to protect its intellectual property and to infringement claims against the company as well as piracy and unlicensed copying.
                          5. Ability to Sell
                          • Demand – risks related to the demand of the company’s goods and services including seasonality, reliance on key customers.
                          • Competition – risks related to the company’s competition including substitutes.
                          • Sales & Marketing – risks related to sales, marketing, and distribution channels, pricing, and market penetration.
                          • Brand & Reputation – risks related to the company’s brand and reputation.
                          6. Macro & Political
                          • Economy & Political Environment – risks related to changes in economic and political conditions.
                          • Natural and Human Disruptions – risks related to catastrophes, floods, storms, terror, earthquakes, coronavirus pandemic/COVID-19.
                          • International Operations – risks related to the global nature of the company.
                          • Capital Markets – risks related to exchange rates and trade, cryptocurrency.